Sign In
Buy AMRN
$14.53
+0.0600 (+0.415%)
At Close: Jun 03, 2026
Amarin: Maximum Optimism
09:34am, Wednesday, 22'nd Sep 2021
Amarin's gross margin has been growing from year to year and by the end of Q2 2021 was around 79.2%, which is significantly higher than the average for the healthcare. Vascepa sales increased 15% in Q
Amarin Outlines New Go-to-Market Strategy to Accelerate VASCEPA® (Icosapent Ethyl) Growth in U.S.
09:15am, Wednesday, 22'nd Sep 2021
Enables Amarin to Drive Additional Demand, Improve Patient Access & Education and Secure Proper Fulfillment and Reimbursement Enables Amarin to Drive Additional Demand, Improve Patient Access & Educat
Amarin to Participate in September Investment Conferences
06:00am, Monday, 13'th Sep 2021
DUBLIN, Ireland and BRIDGEWATER, N.J., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that members of the senior leadership team will participate in two upcomi
7 Busted Biotech Stocks Due for a Rebound
12:25pm, Wednesday, 08'th Sep 2021
Buying biotech stocks while they're down is rewarding once they post positive clinical results, setting the stage for a big rally. The post 7 Busted Biotech Stocks Due for a Rebound appeared first on
Amarin Stock Looks Attractive Despite U.S. Litigations
10:42pm, Thursday, 02'nd Sep 2021
Amarin Stock Looks Attractive Despite U.S. Litigations
VASCEPA found in prespecified and post hoc analyses to reduce first and total primary endpoints by 26% and 35%, respectively, in patients with prior Myocardial Infarction
Amarin (AMRN) Q2 Earnings Top, Vascepa Strong Despite Generics
11:30am, Friday, 06'th Aug 2021
Amarin's (AMRN) Vascepa sales benefit from increased demand in the United States during the second quarter. The drug retains majority market share in its segment amid rising generic competition.
Why Amarin Is Soaring Today
02:34pm, Thursday, 05'th Aug 2021
The pharmaceuticals company is showing surprising resilience in the face of competition.
Amarin Corporation plc's (AMRN) CEO Karim Mikhail on Q2 2021 Results - Earnings Call Transcript
01:29pm, Thursday, 05'th Aug 2021
Amarin Corporation plc's (AMRN) CEO Karim Mikhail on Q2 2021 Results - Earnings Call Transcript
Amarin Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update
06:00am, Thursday, 05'th Aug 2021
Commercial Launch of VAZKEPA in Europe on Track to Commence in September in Germany
Best Penny Stocks to Buy? 3 to Watch In the Second Half of 2021
05:05pm, Wednesday, 04'th Aug 2021
Looking for penny stocks to watch in the second half of 2021? Check these 3 out The post Best Penny Stocks to Buy?
What's in the Cards for Amarin (AMRN) This Earnings Season?
11:28am, Tuesday, 03'rd Aug 2021
Amarin's (AMRN) second-quarter results are likely to reflect recovery in Vascepa sales amid potential recovery in COVID-19 related disruptions.
Amarin: Is It A Buy, Sell, Or Hold? Buy For New Global Expansion
10:26am, Friday, 30'th Jul 2021
Amarin Corporation plc is a global pharmaceutical company focused internationally on commercializing its sole therapeutic, Vascepa. Amarin's sole product is Vascepa, an icosapent ethyl-based cardiovas
7 Reddit Penny Stocks About to Explode
01:45pm, Monday, 19'th Jul 2021
With Reddit's regular targets finally dropping, these stocks could be the next target for another crazy wave of Reddit Penny Stocks. The post 7 Reddit Penny Stocks About to Explode appeared first on I
Amarin to Report Second Quarter and Six Month 2021 Financial Results and Host Conference Call on August 5, 2021
06:35am, Thursday, 15'th Jul 2021
DUBLIN, Ireland and BRIDGEWATER, N.J., July 15, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin senior manageme
